🟢 Painreform is trading 17.4% up in pre-market

Painreform is trading at $0.85 (+17.44%) in pre-market, with no new company-specific announcement identified to explain the move.

• The company’s investor-relations press release list shows its latest listed releases dated September 16 and September 9.
• The Nasdaq was up 0.61% in the supplied market context, but available evidence does not establish that broader sentiment caused the sharp move.
• The company’s investor-relations page showed a last update of October 20, 2026, at 18:16.